$IMUC
EOM Pharmaceutical Holdings, Inc.

2015 Q1 Form 10-Q Financial Statement

#000156459015003958 Filed on May 11, 2015

View on sec.gov

Income Statement

Concept 2015 Q1 2014 Q4 2014 Q1
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $1.100M $920.0K $1.050M
YoY Change 4.76% -14.81% 12.9%
% of Gross Profit
Research & Development $2.065M $1.320M $1.700M
YoY Change 21.5% -7.69% 20.1%
% of Gross Profit
Depreciation & Amortization $6.693K $10.00K $12.63K
YoY Change -47.02% 0.0% 16.53%
% of Gross Profit
Operating Expenses $3.101M $2.240M $2.749M
YoY Change 12.8% -10.76% 94.26%
Operating Profit -$3.101M -$2.749M
YoY Change 12.8% 17.06%
Interest Expense $0.00 $110.0K -$410.0K
YoY Change -100.0% -95.82% -84.41%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$1.425M -$2.130M -$3.162M
YoY Change -54.94% -1875.0% -36.43%
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$1.425M -$2.127M -$3.162M
YoY Change -54.94% -1918.13% -36.43%
Net Earnings / Revenue
Basic Earnings Per Share -$0.03 -$0.05
Diluted Earnings Per Share -$728.2K -$0.03 -$0.05
COMMON SHARES
Basic Shares Outstanding 90.25M 57.57M
Diluted Shares Outstanding

Balance Sheet

Concept 2015 Q1 2014 Q4 2014 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $34.77M $23.22M $25.03M
YoY Change 38.91% -16.02% 3.86%
Cash & Equivalents $34.77M $23.22M $25.03M
Short-Term Investments
Other Short-Term Assets $1.610M $1.220M $730.0K
YoY Change 120.55% 59.82% -10.76%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $36.38M $24.44M $25.76M
YoY Change 41.23% -13.97% 3.36%
LONG-TERM ASSETS
Property, Plant & Equipment $40.00K $47.37K $60.00K
YoY Change -33.33% -28.71% -2.64%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $550.0K $583.5K $460.0K
YoY Change 19.57% 25.59% 411.11%
Total Long-Term Assets $600.0K $736.4K $520.0K
YoY Change 15.38% 38.67% 250.49%
TOTAL ASSETS
Total Short-Term Assets $36.38M $24.44M $25.76M
Total Long-Term Assets $600.0K $736.4K $520.0K
Total Assets $36.98M $25.18M $26.28M
YoY Change 40.72% -13.0% 4.82%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $490.0K $322.0K $570.0K
YoY Change -14.04% -62.6% -19.25%
Accrued Expenses $990.0K $632.7K $740.0K
YoY Change 33.78% 243.88% 104.26%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.490M $1.289M $1.310M
YoY Change 13.74% -8.06% 13.14%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $3.120M $600.0K $1.480M
YoY Change 110.81% -43.4% -72.99%
Total Long-Term Liabilities $3.120M $600.0K $1.480M
YoY Change 110.81% -43.4% -72.99%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.490M $1.289M $1.310M
Total Long-Term Liabilities $3.120M $600.0K $1.480M
Total Liabilities $4.610M $1.887M $2.790M
YoY Change 65.23% -23.61% -57.98%
SHAREHOLDERS EQUITY
Retained Earnings -$61.35M
YoY Change 18.04%
Common Stock $95.13M $84.64M
YoY Change 1470851.84%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $32.37M $23.29M $23.50M
YoY Change
Total Liabilities & Shareholders Equity $36.98M $25.18M $26.28M
YoY Change 40.72% -13.0% 4.82%

Cashflow Statement

Concept 2015 Q1 2014 Q4 2014 Q1
OPERATING ACTIVITIES
Net Income -$1.425M -$2.127M -$3.162M
YoY Change -54.94% -1918.13% -36.43%
Depreciation, Depletion And Amortization $6.693K $10.00K $12.63K
YoY Change -47.02% 0.0% 16.53%
Cash From Operating Activities -$3.050M -$2.110M -$2.614M
YoY Change 16.69% -22.99% 18.42%
INVESTING ACTIVITIES
Capital Expenditures $1.758K $0.00 $3.600K
YoY Change -51.17%
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00 $0.00
YoY Change
Cash From Investing Activities $0.00 $0.00 -$3.200K
YoY Change -100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $431.8K
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 14.60M 1.810M 0.000
YoY Change 90.53% -100.0%
NET CHANGE
Cash From Operating Activities -3.050M -2.110M -2.614M
Cash From Investing Activities 0.000 0.000 -3.200K
Cash From Financing Activities 14.60M 1.810M 0.000
Net Change In Cash 11.55M -300.0K -2.617M
YoY Change -541.35% -83.24% 23.88%
FREE CASH FLOW
Cash From Operating Activities -$3.050M -$2.110M -$2.614M
Capital Expenditures $1.758K $0.00 $3.600K
Free Cash Flow -$3.052M -$2.110M -$2.617M
YoY Change 16.6% -22.99% 18.58%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2015Q1 us-gaap Share Based Compensation
ShareBasedCompensation
205829
CY2014Q1 us-gaap Share Based Compensation
ShareBasedCompensation
184102
CY2015Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
896672
CY2014Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
865402
CY2015Q1 us-gaap Operating Expenses
OperatingExpenses
3101120
CY2014Q1 us-gaap Operating Expenses
OperatingExpenses
2749264
CY2015Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-3101120
CY2014Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-2749264
CY2015Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
3257
CY2014Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
3354
CY2015Q1 imuc Charge To Financing Expense
ChargeToFinancingExpense
88939
CY2014Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
149000000
CY2014Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
63604823
CY2014Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
322002
CY2014Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2014Q4 us-gaap Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
105563
CY2014Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
583464
CY2014Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1289199
CY2014Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
63604823
CY2014Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
334527
CY2014Q4 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
597719
CY2014Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
632670
CY2014Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2014Q4 us-gaap Common Stock Value
CommonStockValue
6360
CY2014Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
84632209
CY2014Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-61346926
CY2014Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
25178561
CY2014Q4 us-gaap Assets
Assets
25178561
CY2015Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
95132062
CY2014Q4 us-gaap Stockholders Equity
StockholdersEquity
23291643
CY2015Q1 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
1761956
CY2014Q1 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
-416067
CY2015Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1424846
CY2014Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-3161977
CY2015Q1 us-gaap Net Income Loss
NetIncomeLoss
-1424846
CY2014Q1 us-gaap Net Income Loss
NetIncomeLoss
-3161977
CY2015Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.02
CY2014Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.05
CY2015Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
77818157
CY2014Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
57552664
CY2015Q1 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
205829
CY2015Q1 us-gaap Depreciation
Depreciation
6693
CY2014Q1 us-gaap Depreciation
Depreciation
12634
CY2014Q1 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
4
CY2015Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
360859
CY2014Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-30927
CY2015Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
170613
CY2014Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-290665
CY2015Q1 us-gaap Increase Decrease In Workers Compensation Liabilities
IncreaseDecreaseInWorkersCompensationLiabilities
-186951
CY2014Q1 us-gaap Increase Decrease In Workers Compensation Liabilities
IncreaseDecreaseInWorkersCompensationLiabilities
-203464
CY2015Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
213552
CY2014Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
398622
CY2015Q1 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-3048986
CY2014Q1 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-2613758
CY2015Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1758
CY2014Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
3600
CY2014Q1 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
400
CY2015Q1 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-1758
CY2014Q1 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-3200
CY2015Q1 imuc Proceeds From Issuance Of Common Stock And Warrants From Underwritten Public Offering
ProceedsFromIssuanceOfCommonStockAndWarrantsFromUnderwrittenPublicOffering
14599627
CY2015Q1 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
14599627
CY2015Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
11548883
CY2014Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-2616958
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
27646351
CY2014Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
25029393
CY2015Q1 us-gaap Certificates Of Deposit At Carrying Value
CertificatesOfDepositAtCarryingValue
33431067
CY2015Q1 us-gaap Use Of Estimates
UseOfEstimates
<div> <p style="margin-bottom:0pt;margin-top:12pt;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;text-indent:4.54%;">Use of Estimates<font style="font-style:normal;"> &#8211; The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make certain estimates and assumptions about the future outcome of current transactions which may affect the reporting and disclosure of these transactions. Accordingly, actual results could differ from those estimates used in the preparation of these financial statements.</font></p></div>
CY2015Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0187
CY2015Q1 us-gaap Common Stock Shares Subscribed But Unissued
CommonStockSharesSubscribedButUnissued
10469540
CY2015Q1 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
0
CY2015Q1 imuc Working Capital
WorkingCapital
34895157
CY2014Q4 imuc Working Capital
WorkingCapital
23152970
CY2015Q1 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2015Q1 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2015Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
40160947
CY2014Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
20551398
CY2015Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
204019
CY2014Q4 us-gaap Certificates Of Deposit At Carrying Value
CertificatesOfDepositAtCarryingValue
10427810
CY2014Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
202261
CY2015Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
161589
CY2014Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
154896
CY2006Q4 us-gaap Payments For Fees
PaymentsForFees
62000
CY2006Q4 imuc Stock Issued During Period Shares Issued For Additional Licensing Fee
StockIssuedDuringPeriodSharesIssuedForAdditionalLicensingFee
100000
CY2014Q1 us-gaap Related Party Costs
RelatedPartyCosts
126237
CY2015Q1 imuc Nonrefundable And Noncreditable License And Maintenance Fee
NonrefundableAndNoncreditableLicenseAndMaintenanceFee
P12M
CY2015Q1 us-gaap Rental Properties
RentalProperties
8063
CY2015Q1 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
25000
CY2014Q1 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
24000
CY2006Q4 us-gaap Stock Issued During Period Shares Issued For Noncash Consideration
StockIssuedDuringPeriodSharesIssuedForNoncashConsideration
694000
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0223
CY2015Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.00
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.00
CY2015Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P7Y1M6D
CY2014Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y
CY2015Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.963
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.953
CY2015Q1 imuc Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Forfeitures Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedForfeituresRate
0.00
CY2014Q1 imuc Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Forfeitures Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedForfeituresRate
0.00
CY2015Q1 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
75990
CY2015Q1 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
68432
CY2015Q1 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
144422
CY2015Q1 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
14500000
CY2015Q1 imuc Stock Issued During Period Shares Private Placement
StockIssuedDuringPeriodSharesPrivatePlacement
26650000
CY2015Q1 imuc Common Stock Shares Issuable Private Placement Warrants
CommonStockSharesIssuablePrivatePlacementWarrants
18655000
CY2015Q1 imuc Common Stock Warrants Exercise Price Private Placement
CommonStockWarrantsExercisePricePrivatePlacement
0.66
CY2015Q1 imuc Common Stock And Warrants Issued For Cash Per Share
CommonStockAndWarrantsIssuedForCashPerShare
0.60
CY2013Q2 imuc Rate Of Commission
RateOfCommission
0.030
CY2013Q2 imuc Listing Of Shares Of Common Stock In Connection With Sales Agreement
ListingOfSharesOfCommonStockInConnectionWithSalesAgreement
10593220
CY2015Q1 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
0
CY2015Q1 imuc Percentage Of Fair Market Value Of Common Stock
PercentageOfFairMarketValueOfCommonStock
not be less than 100%
CY2015Q1 imuc Percentage Of Common Stock Voting Rights Held
PercentageOfCommonStockVotingRightsHeld
more than 10%
CY2015Q1 imuc Minimum Percentage Of Fair Market Value Of Common Stock
MinimumPercentageOfFairMarketValueOfCommonStock
less than 110%
CY2015Q1 imuc Maximum Exercisable Period Of Options
MaximumExercisablePeriodOfOptions
P10Y
CY2015Q1 imuc Maximum Exercisable Period Of Options If Percentage Of Common Stock Voting Rights Held Is More Than Ten Percent
MaximumExercisablePeriodOfOptionsIfPercentageOfCommonStockVotingRightsHeldIsMoreThanTenPercent
P5Y
CY2013Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
12000000
CY2011Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
8000000
CY2005Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
6000000
CY2015Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
260000
CY2015Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
4467731
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
9314765
CY2015Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
1193000
CY2015Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0
CY2015Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
85000
CY2015Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
10422765
CY2015Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
8027189
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.19
CY2015Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0.58
CY2015Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0
CY2015Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
2.25
CY2015Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.24
CY2015Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
1.20
CY2015Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P0Y
CY2015Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P0Y
CY2015Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
11000
CY2015Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
11000
CY2015Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
3000000
CY2015Q1 imuc Employee Service Share Based Compensation Nonvested Awards Compensation Cost Not Yet Recognized Period For Recognition Maximum
EmployeeServiceShareBasedCompensationNonvestedAwardsCompensationCostNotYetRecognizedPeriodForRecognitionMaximum
P17M
CY2015Q1 us-gaap Stock Issued During Period Shares Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
260000
CY2015Q1 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
0.58
CY2010Q2 imuc Warrants Exercisable Period After Initial Issuance
WarrantsExercisablePeriodAfterInitialIssuance
P5Y
CY2011Q1 imuc Warrants Exercisable Period After Initial Issuance
WarrantsExercisablePeriodAfterInitialIssuance
P5Y
CY2012Q4 imuc Common Stock Of Public Offering
CommonStockOfPublicOffering
2823670
imuc Common Stock Of Public Offering
CommonStockOfPublicOffering
2854196
CY2014Q3 imuc Common Stock Of Public Offering
CommonStockOfPublicOffering
2869696
CY2014Q4 imuc Common Stock Of Public Offering
CommonStockOfPublicOffering
2949845
CY2015Q1 imuc Common Stock Of Public Offering
CommonStockOfPublicOffering
3666836
CY2012Q4 imuc Adjusted Exercise Price Of Warrants
AdjustedExercisePriceOfWarrants
1.87
CY2014Q2 imuc Adjusted Exercise Price Of Warrants
AdjustedExercisePriceOfWarrants
1.85
CY2014Q3 imuc Adjusted Exercise Price Of Warrants
AdjustedExercisePriceOfWarrants
1.84
CY2014Q4 imuc Adjusted Exercise Price Of Warrants
AdjustedExercisePriceOfWarrants
1.79
CY2015Q1 imuc Adjusted Exercise Price Of Warrants
AdjustedExercisePriceOfWarrants
1.44
CY2014Q3 imuc Common Stock Shares Purchased Private Placement Warrant
CommonStockSharesPurchasedPrivatePlacementWarrant
3666836
CY2012Q1 imuc Common Stock Warrants Exercise Price Private Placement
CommonStockWarrantsExercisePricePrivatePlacement
1.41
CY2012Q1 imuc Common Stock Shares Issuable Private Placement Warrants
CommonStockSharesIssuablePrivatePlacementWarrants
4744718
CY2012Q1 imuc Warrants Exercisable Period After Initial Issuance
WarrantsExercisablePeriodAfterInitialIssuance
P5Y
CY2015Q1 imuc Common Stock Warrants Exercise Price Private Placement
CommonStockWarrantsExercisePricePrivatePlacement
0.49
CY2014 imuc Common Stock Warrants Exercise Price Private Placement
CommonStockWarrantsExercisePricePrivatePlacement
0.73
CY2012Q1 imuc Adjusted Exercise Price Of Warrants
AdjustedExercisePriceOfWarrants
1.87
CY2014 imuc Adjusted Exercise Price Of Warrants
AdjustedExercisePriceOfWarrants
1.79
CY2012Q4 imuc Common Stock Shares Purchased Private Placement Warrant
CommonStockSharesPurchasedPrivatePlacementWarrant
2823670
CY2012Q1 imuc Charge To Financing Expense
ChargeToFinancingExpense
368524
CY2012Q4 imuc Charge To Financing Expense
ChargeToFinancingExpense
368524
CY2015Q1 imuc Common Stock Shares Purchased Private Placement Warrant
CommonStockSharesPurchasedPrivatePlacementWarrant
2949867
CY2015Q1 imuc Initial Valuation Of Warrants
InitialValuationOfWarrants
2476790
CY2015Q1 us-gaap Financing Interest Expense
FinancingInterestExpense
62683
CY2015Q1 us-gaap Valuation Allowances And Reserves Deductions
ValuationAllowancesAndReservesDeductions
4197375
CY2013Q4 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
1064810
CY2015Q1 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
4286314
CY2014Q1 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
0
CY2015Q1 imuc Warrants Exercised
WarrantsExercised
0
CY2014Q1 imuc Warrants Exercised
WarrantsExercised
0
CY2015Q1 imuc Warrant Liability Gain Loss Included In Earnings
WarrantLiabilityGainLossIncludedInEarnings
1761956
CY2014Q1 imuc Warrant Liability Gain Loss Included In Earnings
WarrantLiabilityGainLossIncludedInEarnings
-416067
CY2015Q1 imuc Warrants Liability Transfers Net
WarrantsLiabilityTransfersNet
0
CY2014Q1 imuc Warrants Liability Transfers Net
WarrantsLiabilityTransfersNet
0
CY2014Q1 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
1480877
CY2015Q1 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
0
CY2014Q1 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
0
CY2015Q1 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
-0.34
CY2014Q1 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
-0.34
CY2015Q1 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
-0.06
CY2014Q1 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
-0.06
CY2015Q1 imuc Change In Fair Value Of Warrant Liability For Income Taxes
ChangeInFairValueOfWarrantLiabilityForIncomeTaxes
1.24
CY2014Q1 imuc Change In Fair Value Of Warrant Liability For Income Taxes
ChangeInFairValueOfWarrantLiabilityForIncomeTaxes
0.05
CY2015Q1 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.84
CY2014Q1 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
0.35
CY2015Q1 us-gaap Effective Income Tax Rate Reconciliation Tax Settlements
EffectiveIncomeTaxRateReconciliationTaxSettlements
0.00
CY2014Q1 us-gaap Effective Income Tax Rate Reconciliation Tax Settlements
EffectiveIncomeTaxRateReconciliationTaxSettlements
0.00
CY2015Q1 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
17060834
CY2014Q1 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
16900628
CY2015Q1 us-gaap Deferred Tax Assets Equity Method Investments
DeferredTaxAssetsEquityMethodInvestments
2315228
CY2014Q1 us-gaap Deferred Tax Assets Equity Method Investments
DeferredTaxAssetsEquityMethodInvestments
2094628
CY2015Q1 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
19376062
CY2014Q1 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
18995256
CY2015Q1 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0
CY2014Q1 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0
CY2015Q1 imuc Net Operating Losses Expire Date
NetOperatingLossesExpireDate
expire in 2022 and 2016

Files In Submission

Name View Source Status
0001564590-15-003958-index-headers.html Edgar Link pending
0001564590-15-003958-index.html Edgar Link pending
0001564590-15-003958.txt Edgar Link pending
0001564590-15-003958-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
g201505112006144682485.jpg Edgar Link pending
g201505112006195782485.jpg Edgar Link pending
g201505112006197342486.jpg Edgar Link pending
imuc-10q_20150331.htm Edgar Link pending
imuc-20150331.xml Edgar Link completed
imuc-20150331.xsd Edgar Link pending
imuc-20150331_cal.xml Edgar Link unprocessable
imuc-20150331_def.xml Edgar Link unprocessable
imuc-20150331_lab.xml Edgar Link unprocessable
imuc-20150331_pre.xml Edgar Link unprocessable
imuc-ex101_20150331104.htm Edgar Link pending
imuc-ex102_20150331201.htm Edgar Link pending
imuc-ex311_201503316.htm Edgar Link pending
imuc-ex312_201503318.htm Edgar Link pending
imuc-ex321_201503317.htm Edgar Link pending
imuc-ex322_201503319.htm Edgar Link pending
imuc-ex41_20150331103.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending